Efficacy on Walking Ability of Electroacupuncture Therapy in Elderly Patients With Sarcopenia
1 other identifier
interventional
120
1 country
1
Brief Summary
Introduction: The efficacy of existing therapies for the treatment of sarcopenia is still not satisfactory. Therefore, this randomized controlled, assessor-blinded study was designed to investigate the efficacy and safety of electroacupuncture(EA) therapy in elderly patients with sarcopenia. Methods and analysis: This randomized controlled trial will enroll 120 elderly patients with sarcopenia. Subjects will be randomly assigned in a 1:1 ratio to either EA combined with rehabilitation training group or rehabilitation training group through a central computerized randomization system. Primary outcome measure is lower limb mobility, including 6-minute walk test、timed get up and go test, and short physical performance battery. Secondary outcome measures include lower limb muscle mass and lower limb muscle strength. Outcome assessment will be conducted before the intervention, at 12 weeks after the intervention and at the end of the 12-week follow-up. Adverse reactions will be evaluated during the trial. Conclusion: This research will provide evidence to clarify whether EA is effective and safe in the treatment of sarcopenia.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jul 2022
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 12, 2022
CompletedFirst Posted
Study publicly available on registry
June 24, 2022
CompletedStudy Start
First participant enrolled
July 2, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2026
ExpectedFebruary 24, 2026
February 1, 2026
3.5 years
June 12, 2022
February 22, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
6min walk test
The 6-min walking test setup is a straight line of 20 meters on a flat floor, and a chair is placed at each end as a sign. The subjects walk back and forth between them. The pace of walking is determined according to their own physical fitness, and they walk as fast as possible. In this way, the maximum walking distance that an individual can reach within 6 minutes will be texted
12 weeks
time to get up and go(TGUG)
The TGUG test measures the time it takes for an individual to get up from a chair, complete a short 3 meters round-trip walk, and finally sit back in the chair.
12 weeks
short physical performance battery (SPPB)
SPPB is a comprehensive test instrument that includes a walking speed test, a sit-to-stand test, and a balance test. The Walking Speed Test measures the time to pass a distance of 4 meters at daily walking speed. Sit-to-stand test is to calculate the time to complete 5 consecutive sets of getting up-sit down. The balance test includes 3 parts: 10 seconds for standing on the left and right side of both feet; standing on half front and half rear feet and standing on front and rear feet
12 weeks
Secondary Outcomes (5)
lower extremity skeletal muscle mass
12 weeks
appendicular skeletal muscle mass(ASMM)
12 weeks
calf circumference
12 weeks
knee flexion and extension strength
12 weeks
grip strength
12 weeks
Study Arms (2)
electroacupuncture and rehabilitation training
EXPERIMENTALParticipants in this group will received electroacupuncture(EA) combined with Otago exercise program(OEP). Acupuncture will be executed with size 0.30×40mm needle. EA will be performed with electronic acupuncture instruments
rehabilitation training only
ACTIVE COMPARATORThe rehabilitation group will be only treated with the Otago exercise program(OEP). The Otago Exercise is a program developed by the research group of fall prevention in the elderly led by Campbell of Otago Medical University in the 1990s. It is a home exercise program aimed at strengthening lower extremity muscle, balance and preventing falls in the elderly. Otago Exercise combines resistance exercise, balance training and aerobic walking and is an exercise prescription for elderly patients with sarcopenia (details are as follows).
Interventions
The rehabilitation training group will be only treated with the Otago exercise program(OEP). Otago Exercise combines resistance exercise, balance training and aerobic walking and is an exercise prescription for elderly patients with sarcopenia. 1. Exercise: including warm-up exercise (5 minutes) + resistance exercise (20 minutes) + balance training (5 minutes). Training intensity: 30 minutes a day, 3 times a week, once every other day, 12 weeks of training period; resistance exercise gradually increases the load. 2. Walking program: Take a walk. Activity intensity: 30 minutes each time, 2 times a week, combined with exercise (walking during the interval between exercise sessions), 12 weeks of training period
Participants are required to be in the supine position. Routine disinfection first. Participants are then subjected to acupuncture and achieve deqi sensation at all acupuncture points. Four paired of acupuncture points (i.e. Biguan acupoints and Futu points; Yanglingquan acupoints and Zusanli acupoints, identical on both sides) are connected to the EA devices. EA parameter is set as sparse wave and frequency is 2Hz. The intensity of the EA is determined by the patients' tolerance. Needles will be left in place and each session of EA will last 30 minutes. Participants will undergo a total of 36 EA sessions, with the frequency of 3 sessions every week for 12 weeks.
Eligibility Criteria
You may qualify if:
- years ≤ age ≤ 95 years, male or female;
- Patients are able to walk and communicate independently, and can complete required rehabilitation training;
- Patients meet the diagnostic criteria proposed by the Asian Working Group for Sarcopenia(AWGS);
- Patients volunteer to participate in this study and sign the informed consent.
You may not qualify if:
- Patients with serious primary diseases of heart, brain, liver, kidney and hematopoietic system;
- Patients with severe mental illness, cognitive impairment, and disorientation;
- Patients have trauma and unsuitable for sports;
- Patients with electronic devices or metal objects implanted in the body;
- Patients can't complete the required rehabilitation training;
- Patients cannot receive EA treatment due to any reasons
- Patients are participating in other drugs, acupuncture and massage trials.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
The Third Affiliated Hospital of Zhejiang Chinese Medical University
Hangzhou, Zhejiang, China
Related Publications (1)
Wu W, Huang X, Fang L, Hu H, Han D. Electroacupuncture Plus Exercise for Sarcopenia in Older Adults: Protocol for a Randomized, Controlled, Assessor-Blinded Trial. Clin Interv Aging. 2025 Oct 23;20:1775-1786. doi: 10.2147/CIA.S545035. eCollection 2025.
PMID: 41164821DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Wenzhe Wu, Master
The Third Affiliated hospital of Zhejiang Chinese Medical University
- PRINCIPAL INVESTIGATOR
Ming Guo, Doctor
Xiyuan Hospital of China Academy of Chinese Medical Sciences
- PRINCIPAL INVESTIGATOR
Hantong Hu, Doctor
The Third Affiliated hospital of Zhejiang Chinese Medical University
- PRINCIPAL INVESTIGATOR
Hong Gao, Master
The Third Affiliated hospital of Zhejiang Chinese Medical University
- PRINCIPAL INVESTIGATOR
Jinkuo Pang, Bachelor
The Third Affiliated hospital of Zhejiang Chinese Medical University
- PRINCIPAL INVESTIGATOR
Yanfei Cao, Master
The Third Affiliated hospital of Zhejiang Chinese Medical University
- PRINCIPAL INVESTIGATOR
Yiting Zhang, Master
The Third Affiliated hospital of Zhejiang Chinese Medical University
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Attending Physician
Study Record Dates
First Submitted
June 12, 2022
First Posted
June 24, 2022
Study Start
July 2, 2022
Primary Completion
December 31, 2025
Study Completion (Estimated)
December 31, 2026
Last Updated
February 24, 2026
Record last verified: 2026-02
Data Sharing
- IPD Sharing
- Will not share
no plan